ARCHIVES

FDA, NCI Seek Compromise On Survival Endpoints

This article is from The Cancer Letter archive.

Vol. 15 No. 24 | June 16, 1989

Download PDF Visit The Full Archive

Related Articles

Black Women More Likely To Have Aggressive, Less Treatable Breast Cancer

September 28, 2007

FDA Approves Xeloda For Breast Cancer Treatment.

September 28, 2001

Blayney Elected ASCO President For 2009.

March 7, 2008

NCI CTEP-Approved Trials For the Month of February

February 28, 2014

DRCCA Organization Still Not Complete; Division Will Chemoprevention

October 3, 1980

Funding Opportunities: Komen Foundation Seeks Reviewers

February 28, 1997